Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX) Meeting Abstract

  

Authors:	Palafox, M.; Herrera-Abreu, M. T.; Bellet, M.; Oliveira, M.; Bruna, A.; Rodriguez, O.; Guzman, M.; Grueso, J.; Vilaplana, C.; Arribas, J.; di Tomaso, E.; Su, F. Y.; Caldas, C.; Turner, N. C.; Dienstmann, R.; Baselga, J.; Scaltriti, M.; Cortes, J.; Saura, C.; Serra, V.
Abstract Title:	Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hormone receptor (HR) positive and HER2-positive breast cancer (BC) patient-derived xenografts (PDX)
Meeting Title:	109th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	78
Issue:	13 Suppl.
Meeting Dates:	2018 Apr 14-18
Meeting Location:	Chicago, IL
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2018-07-01
Language:	English
ACCESSION:	WOS:000468819501391
DOI:	10.1158/1538-7445.Am2018-3596
PROVIDER:	wos
Notes:	Meeting Abstract: 3596 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/148085